Renal Cell Carcinoma

Zusatztext

<p>The third edition of this critically acclaimed book has updated and expanded the survey of clinical, biological and pathological management of localized and advanced renal cell carcinoma. Internationally renowned editors and contributors explore the latest developments in molecular genetics, focusing on the novel targets that have been discovered in epithelial renal tumors.</p><p>Comprehensive and authoritative,<i>Renal Cell Carcinoma: Molecular Targets and Clinical Applications, Third Edition</i> is the definitive text on the rapidly evolving landscape of experimental therapeutics, written and edited by leaders of the field.</p>

Autorenportrait

<p>Ronald M Bukowski MD Emeritus Staff Physician Cleveland Clinic Taussig Cancer Center Professor Emeritus of Medicine CCF Lerner College of Medicine of CWRU</p><p>Robert Figlin MD Professor of Medicine and Biomedical Sciences Director, Division of Hematology Oncology Department of Medicine, Cedars-Sinai Medical Center Associate Director for Academic Programs Samuel Oschin Comprehensive Cancer Institute Professor Emeritus of Medicine and Urology David Geffen School of Medicine at UCLA</p><p>Robert Motzer MD Attending Physician Department of Medicine Memorial Sloan-Kettering Cancer Center Professor of Medicine Weil Medical College of Cornell University </p>

Weitere Details